By 2030, it is anticipated that the Turkey Radiotherapy Market will reach a value of $91 Mn from $55 Mn in 2022, growing at a CAGR of 6.5% during 2022-2030. The Radiotherapy Therapeutics Market in Turkey is dominated by a few domestic players such as Tecnologia en Radioterapia, Medical Plus, and Grupo Gamma. The radiotherapy market in Turkey is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Turkey Radiotherapy is increasing on account of the rise in cancer cases in the country.
By 2030, it is anticipated that the Turkey Radiotherapy Market will reach a value of $91 Mn from $55 Mn in 2022, growing at a CAGR of 6.5% during 2022-30.
Turkey is an upper middle-income, developing transcontinental country located in Southeastern Europe and Southwestern Asia bordering the Black Sea. Acibadem is a well-known name in Turkish medicine. According to the most recent WHO figures, there will be 2,33,834 new cancer cases in Turkey in 2020. The cancer registry conducts epidemiological studies on behalf of the Ministry of Health and creates Turkey's cancer control policies and national programs.
Turkey boasts one of the most well-known social security systems in the world, with free healthcare and access to cutting-edge cancer treatments. Turkey's government spent 4.6% of its GDP on healthcare in 2020.
Market Growth Drivers Analysis
The Ministry of Health established the National Cancer Control Program with the purpose of avoiding cancer, finding it early, delivering high-quality treatment, and enhancing the quality of life of cancer patients. Radiation oncology is an important component of the multidisciplinary treatment strategy in Turkey. There will be 593 active radiation oncologists by December 2021. With an increasing number of patients seeking high-quality, low-cost cancer care, Turkey has become a popular medical tourism destination. These aspects could boost Turkey's, Radiotherapy Market.
Market restrains.
In general, Turkey's radiation oncology facilities are developing, with more radiotherapy centres and precise technology than ever before, however, there is a large regional disparity in equipment distribution. Oncology surgeries in Turkey cost an average of $65,250. The high cost of the treatment may limit its affordability and accessibility among patients. Diagnostic and therapeutic facilities are not evenly spread throughout the country, and it is vital to provide access to modern diagnostic and therapeutic facilities in rural areas. These factors may deter new entrants into the Turkey Radiotherapy Market.
Key Players
April 2023: Acibadem Healthcare Group, Turkey's leading cancer treatment provider, proudly unveils the ground-breaking ETHOS radiation therapy device. This cutting-edge linear accelerator uses artificial intelligence (AI) to improve radiotherapy precision, adaptability, and efficiency. Acibadem, the first healthcare provider in Turkey and the area to offer ETHOS therapy continues to set the standard for innovative cancer treatment.
In Turkey, the regulations and reimbursement of radiotherapy are overseen by the Ministry of Health and the Social Security Institution (SSI). The Turkish Society for Radiation Oncology (TROD) is the main professional organization for radiation oncologists in Turkey and works closely with the Ministry of Health to develop guidelines and standards of practice for radiotherapy. The SSI is responsible for administering the public healthcare system in Turkey, including reimbursement for radiotherapy services.
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type (Revenue, USD Billion):
?By Technology (Revenue, USD Billion):
By Application (Revenue, USD Billion):
By End User (Revenue, USD Billion):
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.